MARKET

ALT

ALT

Altimmune
NASDAQ
2.985
-0.095
-3.08%
Opening 15:20 07/07 EDT
OPEN
3.080
PREV CLOSE
3.080
HIGH
3.120
LOW
2.960
VOLUME
3.41M
TURNOVER
--
52 WEEK HIGH
6.44
52 WEEK LOW
2.560
MARKET CAP
580.51M
P/E (TTM)
-3.2298
1D
5D
1M
3M
1Y
5Y
1D
Altimmune: Pemvidutide AUD Data Due Q3 Makes For Intriguing Catalyst - Upgrade
Seeking Alpha · 7h ago
Weekly Report: what happened at ALT last week (0629-0703)?
Weekly Report · 1d ago
Weekly Report: what happened at ALT last week (0622-0626)?
Weekly Report · 06/29 09:03
BWXT, Altimmune, Global Payments, AbbVie, Nike Trending With Analysts
TipRanks · 06/27 09:00
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
NASDAQ · 06/26 08:59
5 Small Drug Stocks to Invest in Amid a Biotech Comeback
NASDAQ · 06/25 12:40
Noteworthy Wednesday Option Activity: ALT, SEZL, BE
NASDAQ · 06/24 20:00
10 small-cap U.S. healthcare stocks with the weakest momentum grades
Seeking Alpha · 06/24 14:20
More
About ALT
Altimmune, Inc. is a late clinical-stage biopharmaceutical company. The Company is developing novel therapies for serious liver diseases. Its lead product candidate, pemvidutide (formerly ALT-801), is a balanced 1:1 glucagon/GLP-1 dual receptor agonist in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD) and alcohol-associated liver disease (ALD). The activation of glucagon receptors results in direct effects on the liver, including reductions in liver fat, inflammation and fibrosis, whereas the activation of GLP-1 receptors mediates suppression of appetite and reduction of cravings as well as metabolic effects such as weight loss. It has completed phase II development of pemvidutide. It also develops and commercializes surfactant-functionalized (EuPort domain) incretin-based peptide therapeutics, including (GLP-1-glucagon)/oxyntomodulin, and variants.

Webull offers Altimmune Inc stock information, including NASDAQ: ALT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALT stock methods without spending real money on the virtual paper trading platform.